Fox Jennifer Lynne bought MYGN
November 1, 2026 · Form 4 insider transaction
Fox Jennifer Lynne bought 39,370 shares of Myriad Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
39,370
Price
$0.00
Total value
N/A
InsiderFox Jennifer Lynne
Role—
CompanyMyriad Genetics, Inc. (MYGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateNovember 1, 2026
Filing dateNovember 2, 2026
Shares owned after345,334
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of time-based restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.